Abiopharma

New Form 8-K - Vyome Holdings, Inc Filed: 2025-09-02 AccNo: 0001213900-25-082924 Size: 5 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions

Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board

IMUNON to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Johnson & Johnson - Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study onVARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress

New Form 8-K - THERMO FISHER SCIENTIFIC INC. Filed: 2025-09-02 AccNo: 0000097745-25-000111 Size: 354 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

SenesTechs Evolve™ Deployments Expanded to Additional Chicago Neighborhoods

ImmunoPrecise - ImmunoPrecise Antibodies to Participate at H.C. Wainwrights 27th Annual Global Investment Conference in New York

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel

Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference

Replimune Announces Type A Meeting Scheduled with FDA

Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

CRISPR Therapeutics to Participate in Upcoming Investor Conferences